+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Deep Brain Stimulation in Parkinson's Disease Market Research Report by Product (Dual Channel and Single Channel), End-user, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 147 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5532725
UP TO OFF until Dec 31st 2022
The United States Deep Brain Stimulation in Parkinson’s Disease Market size was estimated at USD 174.42 million in 2021, USD 195.34 million in 2022, and is projected to grow at a CAGR 14.05% to reach USD 384.01 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Deep Brain Stimulation in Parkinson’s Disease to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Dual Channel and Single Channel.
  • Based on End-user, the market was studied across Ambulatory Surgical Centers, Hospitals, Neurology Clinics, and Research Centers.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Deep Brain Stimulation in Parkinson’s Disease market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Deep Brain Stimulation in Parkinson’s Disease Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Deep Brain Stimulation in Parkinson’s Disease Market, including Abbott Laboratories, Aleva Neurotherapeutics SA, Allergan Plc, Beijing PINS Medical Co. Ltd, Boston Scientific Corporation, Cyberonics, Inc, Fisher Wallace, Functional Neuromodulation Ltd, LIVANOVA PLC, Medtronic PLC, MicroTransponder Inc, Neuronetics Inc., NeuroPace Inc., NeuroSigma, Inc., Nevro Corporation, Nexstim Oy, Renishaw PLC, ReShape Lifesciences, Inc, Synapse Biomedical Inc, and Zynex, Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Deep Brain Stimulation in Parkinson’s Disease Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Deep Brain Stimulation in Parkinson’s Disease Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Deep Brain Stimulation in Parkinson’s Disease Market?
4. What is the competitive strategic window for opportunities in the United States Deep Brain Stimulation in Parkinson’s Disease Market?
5. What are the technology trends and regulatory frameworks in the United States Deep Brain Stimulation in Parkinson’s Disease Market?
6. What is the market share of the leading vendors in the United States Deep Brain Stimulation in Parkinson’s Disease Market?
7. What modes and strategic moves are considered suitable for entering the United States Deep Brain Stimulation in Parkinson’s Disease Market?
Frequently Asked Questions about the U.S. Deep Brain Stimulation in Parkinson’s Disease Market

What is the estimated value of the U.S. Deep Brain Stimulation in Parkinson’s Disease Market?

The U.S. Deep Brain Stimulation in Parkinson’s Disease Market was estimated to be valued at $174.42 Million in 2021.

What is the growth rate of the U.S. Deep Brain Stimulation in Parkinson’s Disease Market?

The growth rate of the U.S. Deep Brain Stimulation in Parkinson’s Disease Market is 14.0%, with an estimated value of $384.01 Million by 2027.

What is the forecasted size of the U.S. Deep Brain Stimulation in Parkinson’s Disease Market?

The U.S. Deep Brain Stimulation in Parkinson’s Disease Market is estimated to be worth $384.01 Million by 2027.

Who are the key companies in the U.S. Deep Brain Stimulation in Parkinson’s Disease Market?

Key companies in the U.S. Deep Brain Stimulation in Parkinson’s Disease Market include Abbott Laboratories, Aleva Neurotherapeutics SA, Allergan Plc, Beijing PINS Medical Co. Ltd, Boston Scientific Corporation, Cyberonics, Inc, Fisher Wallace, Functional Neuromodulation Ltd and Medtronic PLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Deep Brain Stimulation in Parkinson’s Disease Market, by Product
6.1. Introduction
6.2. Dual Channel
6.3. Single Channel
7. Deep Brain Stimulation in Parkinson’s Disease Market, by End-user
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Hospitals
7.4. Neurology Clinics
7.5. Research Centers
8. California Deep Brain Stimulation in Parkinson’s Disease Market9. Florida Deep Brain Stimulation in Parkinson’s Disease Market10. Illinois Deep Brain Stimulation in Parkinson’s Disease Market11. New York Deep Brain Stimulation in Parkinson’s Disease Market12. Ohio Deep Brain Stimulation in Parkinson’s Disease Market13. Pennsylvania Deep Brain Stimulation in Parkinson’s Disease Market14. Texas Deep Brain Stimulation in Parkinson’s Disease Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbott Laboratories
16.2. Aleva Neurotherapeutics SA
16.3. Allergan Plc
16.4. Beijing PINS Medical Co. Ltd
16.5. Boston Scientific Corporation
16.6. Cyberonics, Inc
16.7. Fisher Wallace
16.8. Functional Neuromodulation Ltd
16.9. LIVANOVA PLC
16.10. Medtronic PLC
16.11. MicroTransponder Inc
16.12. Neuronetics Inc.
16.13. NeuroPace Inc.
16.14. NeuroSigma, Inc.
16.15. Nevro Corporation
16.16. Nexstim Oy
16.17. Renishaw PLC
16.18. ReShape Lifesciences, Inc
16.19. Synapse Biomedical Inc
16.20. Zynex, Inc
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET DYNAMICS
FIGURE 8. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DUAL CHANNEL, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY SINGLE CHANNEL, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2027
FIGURE 18. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY HOSPITALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, 2019-2027 (USD MILLION)
FIGURE 23. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY RESEARCH CENTERS, 2019-2027 (USD MILLION)
FIGURE 25. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 26. CALIFORNIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. FLORIDA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. ILLINOIS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. NEW YORK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. OHIO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. PENNSYLVANIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. TEXAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 34. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 35. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY DUAL CHANNEL, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY SINGLE CHANNEL, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY NEUROLOGY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY RESEARCH CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. CALIFORNIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 14. CALIFORNIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 15. CALIFORNIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 16. FLORIDA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 17. FLORIDA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 18. FLORIDA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 19. ILLINOIS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 20. ILLINOIS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 21. ILLINOIS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 22. NEW YORK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 23. NEW YORK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 24. NEW YORK DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 25. OHIO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. OHIO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 27. OHIO DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 28. PENNSYLVANIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. PENNSYLVANIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 30. PENNSYLVANIA DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 31. TEXAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. TEXAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 33. TEXAS DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 35. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 36. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 37. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET RANKING
TABLE 38. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 39. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET MERGER & ACQUISITION
TABLE 40. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 41. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 42. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET INVESTMENT & FUNDING
TABLE 43. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 44. UNITED STATES DEEP BRAIN STIMULATION IN PARKINSON’S DISEASE MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Aleva Neurotherapeutics SA
  • Allergan Plc
  • Beijing PINS Medical Co. Ltd
  • Boston Scientific Corporation
  • Cyberonics, Inc
  • Fisher Wallace
  • Functional Neuromodulation Ltd
  • LIVANOVA PLC
  • Medtronic PLC
  • MicroTransponder Inc
  • Neuronetics Inc.
  • NeuroPace Inc.
  • NeuroSigma, Inc.
  • Nevro Corporation
  • Nexstim Oy
  • Renishaw PLC
  • ReShape Lifesciences, Inc
  • Synapse Biomedical Inc
  • Zynex, Inc

Methodology

Loading
LOADING...